Eclipse Bioinnovations
Eclipse Bioinnovations is a data-driven company specializing in next-generation sequencing assays and bioinformatics workflows to support RNA-based and RNA-targeting therapeutic development. Their proprietary technology portfolio, including eMERGE for RNA medicines and eVERSE for AI-ready RNA datasets, provides actionable insights into RNA potency, stability, safety, and biology. They serve biopharma and biotech companies with multiomic profiling, target discovery, and validation solutions, enabling clinical trial success. With over 30 publications and partnerships with more than 15 major biopharma and 40 biotech companies, Eclipsebio is positioned as a leading partner in RNA medicine development.
Eclipse Bioinnovations
Eclipse Bioinnovations is a data-driven company specializing in next-generation sequencing assays and bioinformatics workflows to support RNA-based and RNA-targeting therapeutic development. Their proprietary technology portfolio, including eMERGE for RNA medicines and eVERSE for AI-ready RNA datasets, provides actionable insights into RNA potency, stability, safety, and biology. They serve biopharma and biotech companies with multiomic profiling, target discovery, and validation solutions, enabling clinical trial success. With over 30 publications and partnerships with more than 15 major biopharma and 40 biotech companies, Eclipsebio is positioned as a leading partner in RNA medicine development.